ATNM
Actinium Pharmaceuticals Inc
1.20$
+1.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -57.2% | -12.4% | -90.1% | +3,987.0% | -95.2% | +0.0% | +153.3% | -100.0% | – | – | – | -100.0% | – | – | – | -100.0% | – | – | -100.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | +31.4% | +22.8% | -27.1% | +13.0% | +14.8% | -4.3% | -0.5% | +8.5% | -12.5% | +6.9% | +1.0% | +0.5% | -0.5% | +1.0% | -398.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -57.2% | -12.4% | -148.9% | – | -116.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | +583.3% | -135.8% | – | – | |
| – | -31.4% | +15.4% | -2.8% | +13.2% | -25.9% | +21.5% | -25.5% | +26.9% | +20.5% | -14.7% | -7.5% | +20.4% | -30.2% | +23.0% | -15.5% | +8.0% | +22.5% | -7.8% | -15.1% | +29.7% | +12.1% | -19.8% | +5.9% | +46.1% | +9.5% | +9.4% | +38.5% | +5.1% | -30.7% | -18.9% | +34.5% | +10.8% | -51.9% | +67.1% | -36.6% | -12.9% | +15.6% | -14.5% | +28.0% | – | |
| – | +108.2% | +12.9% | -14.3% | -38.5% | -22.5% | +40.3% | -16.2% | +24.6% | -33.0% | +3.6% | -21.0% | +69.3% | -30.9% | +21.6% | -24.7% | +58.1% | -1.6% | -4.3% | -0.5% | +16.6% | +33.1% | -34.7% | +86.3% | -4.9% | +28.8% | -5.6% | +22.1% | -40.2% | -15.5% | +28.4% | +21.3% | -21.3% | -4.7% | +231.8% | -70.6% | -41.5% | +38.0% | -19.6% | +20.9% | – | |
| – | -3.9% | +14.3% | -7.7% | -7.1% | -22.2% | +22.0% | -22.7% | +26.1% | +2.7% | -10.4% | -10.8% | +30.8% | -30.3% | +22.7% | -18.0% | +20.4% | +14.6% | -6.9% | -10.9% | +25.5% | +18.4% | -24.8% | +29.3% | +24.7% | +15.7% | +4.1% | +33.2% | -8.3% | -27.7% | -8.3% | +30.4% | +1.4% | -41.1% | +127.9% | -54.9% | -22.9% | +21.6% | -19.1% | +30.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1,403.6% | -100.0% | – | – | +10,981.6% | -100.0% | – | – | – | -83.3% | +105.4% | -10.7% | – | – | +184.6% | +97.3% | -24.7% | -5.5% | +3.8% | -14.8% | -17.4% | -7.9% | +137.1% | +291.6% | +98.2% | -15.1% | -15.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | – | – | – | – | – | – | – | – | – | – | -264.6% | – | – | – | – | +14.9% | – | – | – | – | – | – | – | – | – | – | +175.7% | +128.3% | -68.4% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.